Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.
dc.contributor.author | Rangel, ML | |
dc.contributor.author | Alghamdi, I | |
dc.contributor.author | Contreras, G | |
dc.contributor.author | Harrington, T | |
dc.contributor.author | Thomas, DB | |
dc.contributor.author | Barisoni, L | |
dc.contributor.author | Andrews, D | |
dc.contributor.author | Wolf, M | |
dc.contributor.author | Asif, A | |
dc.contributor.author | Nayer, A | |
dc.date.accessioned | 2021-04-01T15:02:52Z | |
dc.date.available | 2021-04-01T15:02:52Z | |
dc.date.issued | 2013-07 | |
dc.date.updated | 2021-04-01T15:02:52Z | |
dc.description.abstract | Antiphospholipid syndrome (APS) is a distinct autoimmune prothrombotic disorder due to pathogenic autoantibodies directed against proteins that bind to phospholipids. APS is characterized by arterial and venous thrombosis and their clinical sequelae. Catastrophic antiphospholipid syndrome (CAPS) is a rare and often fatal form of APS characterized by disseminated intravascular thrombosis and ischemic injury resulting in multiorgan failure. Rarely, intravascular thrombosis in CAPS is accompanied by hemorrhagic manifestations such as diffuse alveolar hemorrhage. Here, we report a 43-year-old woman who presented with anemia, acute gastroenteritis, abnormal liver function tests, bilateral pulmonary infiltrates, and a systemic inflammatory response syndrome. The patient developed respiratory failure as a result of diffuse alveolar hemorrhage followed by acute renal failure. Laboratory tests disclosed hematuria, proteinuria, and reduced platelet count. Microbiologic tests were negative. A renal biopsy demonstrated acute thrombotic microangiopathy and extensive interstitial hemorrhage. Serologic tests disclosed antinuclear antibodies and reduced serum complement C4 concentration. Coagulation studies revealed the lupus anticoagulant and autoantibodies against cardiolipin, beta 2-glycoprotein I, and prothrombin. High-dose glucocorticoids and plasma exchange resulted in rapid resolution of pulmonary, renal, and hematological manifestations. This rare case emphasizes that CAPS can present with concurrent thrombotic and hemorrhagic manifestations. Rapid diagnosis and treatment may result in complete recovery. | |
dc.identifier | 0961203313491024 | |
dc.identifier.issn | 0961-2033 | |
dc.identifier.issn | 1477-0962 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | SAGE Publications | |
dc.relation.ispartof | Lupus | |
dc.relation.isversionof | 10.1177/0961203313491024 | |
dc.subject | Pulmonary Alveoli | |
dc.subject | Humans | |
dc.subject | Respiratory Insufficiency | |
dc.subject | Thrombosis | |
dc.subject | Antiphospholipid Syndrome | |
dc.subject | Catastrophic Illness | |
dc.subject | Hemorrhage | |
dc.subject | Antibodies, Antinuclear | |
dc.subject | Glucocorticoids | |
dc.subject | Plasma Exchange | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Adult | |
dc.subject | Female | |
dc.title | Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. | |
dc.type | Journal article | |
duke.contributor.orcid | Barisoni, L|0000-0003-0848-9683 | |
duke.contributor.orcid | Wolf, M|0000-0002-1127-1442 | |
pubs.begin-page | 855 | |
pubs.end-page | 864 | |
pubs.issue | 8 | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Pathology | |
pubs.organisational-group | Medicine, Nephrology | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Population Health Sciences | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Basic Science Departments | |
pubs.publication-status | Published | |
pubs.volume | 22 |
Files
Original bundle
- Name:
- 2013Lupus_rangel_APAS_catastrophic.pdf
- Size:
- 598.08 KB
- Format:
- Adobe Portable Document Format